Dr Danny Gelman

Danny specialises in the drafting and prosecution of global patent families for chemical inventions, with a focus on the pharmaceutical/medicinal chemistry sectors. Danny’s experience covers the entire patent life cycle. He advises clients at every stage, from the patent-related aspects of experimental design, development of appropriate IP strategies and drafting patent specifications to build investable patent portfolios, to obtaining globally enforceable rights, and advising on pre-product launch infringement risks. Danny holds a PhD in organic synthetic chemistry from Monash University. During his PhD studies, Danny was awarded a Fulbright Scholarship enabling him to further his research at Harvard University. Danny has worked as a senior scientist in drug discovery in the UK pharmaceutical industry. Danny also completed a course in technology-based entrepreneurship at the Saïd Business School at Oxford University. Danny’s experience gives him a deep understanding of the journey that an invention takes from conception through to commercialisation. This allows him to identify valuable aspects of an invention and build investable patent portfolios to help his clients succeed.